MMP1 and neoplasm: Since orobol showed a potent anti-skin-aging effect via the inhibition of MMP-1 expression at a concentration range of 4–8 μM [15], it can be claimed that the prepared NLCs formulation can provide sufficient epidermal/dermal orobol concentration to exert its anti-skin-aging effect.